Meiji Yasuda Asset Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $412K | Sell |
1,434
-527
| -27% | -$151K | 0.02% | 369 |
|
|
2025
Q1 | $605K | Sell |
1,961
-19
| -1% | -$5.86K | 0.02% | 396 |
|
|
2024
Q4 | $699K | Sell |
1,980
-12
| -0.6% | -$4.23K | 0.03% | 372 |
|
|
2024
Q3 | $714K | Sell |
1,992
-55
| -3% | -$19.7K | 0.03% | 359 |
|
|
2024
Q2 | $652K | Buy |
2,047
+33
| +2% | +$10.5K | 0.03% | 370 |
|
|
2024
Q1 | $463K | Buy |
2,014
+378
| +23% | +$86.8K | 0.02% | 447 |
|
|
2023
Q4 | $360K | Buy |
1,636
+80
| +5% | +$17.6K | 0.02% | 443 |
|
|
2023
Q3 | $351K | Buy |
+1,556
| New | +$351K | 0.02% | 496 |
|
|
2019
Q1 | – | Sell |
-2,000
| Closed | -$218K | – | 476 |
|
|
2018
Q4 | $218K | Sell |
2,000
-400
| -17% | -$43.6K | 0.02% | 440 |
|
|
2018
Q3 | $307K | Buy |
2,400
+200
| +9% | +$25.6K | 0.03% | 430 |
|
|
2018
Q2 | $249K | Hold |
2,200
| – | – | 0.02% | 451 |
|
|
2018
Q1 | $247K | Hold |
2,200
| – | – | 0.02% | 455 |
|
|
2017
Q4 | $325K | Buy |
2,200
+210
| +11% | +$31K | 0.03% | 431 |
|
|
2017
Q3 | $233K | Buy |
+1,990
| New | +$233K | 0.02% | 464 |
|
|
2017
Q2 | – | Sell |
-2,890
| Closed | -$391K | – | 507 |
|
|
2017
Q1 | $391K | Sell |
2,890
-300
| -9% | -$40.6K | 0.04% | 392 |
|
|
2016
Q4 | $458K | Sell |
3,190
-100
| -3% | -$14.4K | 0.05% | 352 |
|
|
2016
Q3 | $388K | Buy |
3,290
+460
| +16% | +$54.2K | 0.05% | 362 |
|
|
2016
Q2 | $300K | Buy |
2,830
+290
| +11% | +$30.7K | 0.04% | 366 |
|
|
2016
Q1 | $283K | Buy |
2,540
+250
| +11% | +$27.9K | 0.06% | 280 |
|
|
2015
Q4 | $359K | Buy |
+2,290
| New | +$359K | 0.08% | 242 |
|